Concurrent Radiation and Immunotherapy for Unresectable Hepatocellular Carcinoma With Extensive Portal Vein Tumor Thrombus
Purpose: While immunotherapy has been established as the standard of care for patients with Barcelona Clinic for Liver Cancer class C hepatocellular carcinoma (HCC), outcomes for patients with portal vein thrombus (PVT) remain poor. This study evaluates the benefit of radiation therapy (RT) in addit...
Saved in:
| Main Authors: | Nithya Krishnamurthy, BA, Daniel Cherry, MD, Carlos Rodriguez-Russo, MD, Michael Buckstein, MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-10-01
|
| Series: | Advances in Radiation Oncology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2452109425001435 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of sorafenib in Chinese unresectable hepatocellular carcinoma patients with prior surgery and portal vein tumor thrombosis: A subset analysis of GIDEON study data
by: Sheng-Long Ye, et al.
Published: (2017-03-01) -
Portal vein reconstruction in iatrogenic portal vein ligation
by: Tony Rizk, et al.
Published: (2025-03-01) -
Management strategies for advanced hepatocellular carcinoma with portal vein tumor thrombosis
by: Jeayeon Park, et al.
Published: (2025-01-01) -
Lenvatinib combined with anti-PD-1 antibodies plus locoregional treatment for initial unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a multicenter real-world study
by: Qi-Yu Chi, et al.
Published: (2025-07-01) -
Percutaneous Transsplenic Balloon-Assisted Transjugular Intrahepatic Portosystemic Shunt Placement for Chronic Noncirrhotic Obliterative Portal Vein Thrombus
by: Rajesh Sasidharan, et al.